13th Feb 2007 18:07
GlaxoSmithKline PLC13 February 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 9 February 2007 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 12 February 2007 that 5,805 Ordinary shares in the Company had been sold on 9 February 2007 on behalf of participants in the SmithKline Beecham Annual Investment Plan at a price of £14.51 per share. The Trust also notified the Company on 12 February 2007 that 18,851 Ordinary shares had been transferred from the Trust to participants in the SmithKline Beecham Annual Investment Plan. The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, Mr J S Heslop is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 13 February 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline